Large gap with delayed quotes
|
Last quote
09/03/2025
-
21:23:32
|
Bid
09/03/2025 -
21:23:37
|
Bid Volume |
Ask
09/03/2025 -
21:23:37
|
Ask Volume |
|---|---|---|---|---|
|
13.35
-0.15
(
-1.11% )
|
13.34
|
100 |
13.36
|
100 |
Analysis date: 02.09.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 29.07.2025.
Interest
Strong
Strong
Three stars since 01.08.2025.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 29.07.2025 at a price of 9.20.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 01.08.2025.
4wk Rel Perf
31.48%
31.48%
The four-week dividend-adjusted overperformance versus SP500 is 31.48%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.12%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 6.35%.
Mkt Cap in $bn
1.92
1.92
With a market capitalization <$2bn, DYNE THERAPEUTICS is considered a small-cap stock.
G/PE Ratio
0.66
0.66
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
-4.22
-4.22
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
2.80%
2.80%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
128
128
For 1% of index variation, the stock varies on average by 1.28%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
10.86
10.86
The value at risk is estimated at USD 10.86. The risk is therefore 80.47%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025